US Fertility Appears in 5.5% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Mark HuntleyBy Mark HuntleyFounder and CEO
10 minutes read

Key Takeaways

  • US Fertility was mentioned in 26 of 477 benchmark answers, but received only 1 recommendation and no top-three or first-place placements.
  • The main issue is the gap between mentions and endorsements, with most appearances framed neutrally rather than as a clear choice.
  • Conflicting claims cluster around ownership and investors, so the first step is to verify those details against primary sources.
  • The most-cited company pages and recurring buyer questions suggest where approved facts and clearer explanations are most needed.

Answer Capsule

In November 2026, US Fertility appeared in 26 of 477 AI answers included in the IVF Clinics benchmark (5.45%). It received 1 recommendation (0.21%), with 0 Top 3 placements and 0 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

  • How do US Fertility mentions, recommendations and placements compare with its IVF Clinics peers?

US Fertility recorded 26 mentions (5.45%) and 1 recommendation (0.21%) across 477 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 3 positive, 22 neutral and 1 negative.

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

CCRM Fertility

222

46.54%

135

28.30%

98

20.55%

44

9.22%

2

Shady Grove Fertility

199

41.72%

99

20.75%

78

16.35%

22

4.61%

3

RMA Network

155

32.49%

86

18.03%

50

10.48%

17

3.56%

4

Columbia University Fertility Center

62

13.00%

58

12.16%

49

10.27%

33

6.92%

5

Spring Fertility

65

13.63%

38

7.97%

20

4.19%

5

1.05%

6

Pacific Fertility Center

62

13.00%

35

7.34%

23

4.82%

8

1.68%

7

Kindbody

68

14.26%

27

5.66%

3

0.63%

1

0.21%

8

Boston IVF

43

9.01%

23

4.82%

10

2.10%

7

1.47%

9

Extend Fertility

37

7.76%

7

1.47%

1

0.21%

0

0.00%

10

US Fertility

26

5.45%

1

0.21%

0

0.00%

0

0.00%

US Fertility appears in a modest share of benchmark answers, but those appearances rarely carry an affirmative recommendation. The gap between mentions and endorsements is the central visibility issue: the company is present in the conversation without being put forward as a choice. That distinction matters because a neutral mention gives a prospective patient little reason to act.

Framing among the recorded mentions was mostly neutral, with a small positive and a single negative. Neutral framing is not the same as endorsement, and the report does not establish why recommendations are scarce. The practical response is to examine what the answers say about the company and whether its own pages give a clear, verifiable reason to recommend it.

What changed since last month

Questions This Section Answers

  • How did US Fertility counts and coverage differ across the available monthly snapshots?

Metric

Nov 2026

Mentions

26 / 477 (5.45%)

Recommendations

1 / 477 (0.21%)

Top 3 recommendations

0 / 477 (0.00%)

#1 recommendations

0 / 477 (0.00%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

This edition is the first broad baseline, so the monthly figures describe a starting position rather than a movement from earlier editions. Earlier editions used a narrower question set, which makes direct comparison with them unreliable. The observed counts should be read as a snapshot of this sample.

Because the baseline is new, the useful comparison is forward-looking: future editions screened the same way can be set against it. For now, the agency would treat this month as the reference point and avoid drawing conclusions about direction from a single sample.

AI recommendation trend

Observed recommendation rate (%), Nov 2026

  • US Fertilityno change
    Nov 20260.21%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

Step 1. Measure

Questions This Section Answers

  • What should the agency measure and verify first for US Fertility?

AI answers contained 5 conflicting claims about US Fertility: 0 critical, 5 high, 0 medium, 0 low. Of these, 5 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

A visibility comparison would place US Fertility's presence and endorsement share beside the clinics that appear most often, so the client can see where the distance is widest. Separately, the recorded claims about the company give a concrete list to fact-check. Five claims were rated high priority, and none critical, which suggests a focused review rather than a broad audit.

The two pieces work together: the comparison sets where attention goes, and the claim list sets what needs verification first. Neither establishes that any publisher or the company made an error.

Step 2. Make the website consistent

Questions This Section Answers

  • Which recorded claim differences about US Fertility should be verified before proposed page edits?

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

ownership structure / investors

high

Owned by Amulet and L Catterton plus physician partners, with StepStone Group becoming lead investor in a 2026 recapitalization

Formed as a partnership between Amulet Capital Partners and Shady Grove Fertility; physician-owned and physician-led

ownership structure / investors

high

Owned by L Catterton and Amulet Capital as co-leads, plus physician partners and management; no StepStone

Owned by Amulet and L Catterton plus physician partners, with StepStone Group becoming lead investor in a 2026 recapitalization

ownership structure / investors

high

Owned by L Catterton and Amulet Capital as co-leads, plus physician partners and management; no StepStone

Formed as a partnership between Amulet Capital Partners and Shady Grove Fertility; physician-owned and physician-led

ownership structure / investors

high

Owned by L Catterton and Amulet Capital as co-leads, plus physician partners and management; no StepStone

Owned by Amulet and L Catterton plus physician partners, with StepStone Group becoming lead investor in a 2026 recapitalization

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

The disputed claims cluster around ownership structure and investors, including whether a recapitalization brought in a new lead investor and how physician ownership is described. The recorded answers conflict with each other, and both columns are AI output rather than verified fact. Different dates may explain part of the apparent conflict.

The proposed work is verification first: confirm the entity, the date and the primary source before deciding whether any correction is warranted. Only then would the agency draft conditional page briefs, and only for claims that survive that check. Ambiguous matches would stay out of the correction queue.

Step 3. Align the external narrative

Questions This Section Answers

  • Which cited third-party pages are relevant to fact review for US Fertility?

Cited page selected for review

Citation appearances in all captured answers

Answers mentioning the company

Conflicting claims linked to this page

https://prnewswire.com/news-releases/us-fertility-forms-strategic-partnership-to-accelerate-growth-and-expand-access-to-advanced-reproductive-care-302625613.html

2

2

4

https://linkedin.com/company/usfertility

4

4

3

https://amuletcapital.com/news/usf-and-ovation-fertility-to-combine-to-form-leading-national-fertility-platform/

1

1

3

https://businesswire.com/news/home/20200922005342/en/US-Fertility-Becomes-the-Largest-Physician-Owned-Physician-Led-Network-of-Fertility-Practices-in-the-Nation

1

1

3

https://femtechinsider.com/us-fertility-announces-partnership-with-l-catterton-as-new-co-lead-investor/

1

1

3

https://prnewswire.com/news-releases/us-fertility-announces-ceo-transition-301630925.html

1

1

3

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

The cited pages selected for review include press releases, an investor page, a trade article and the company's LinkedIn profile. Several are linked to multiple conflicting claims, which makes them sensible starting points for a source review. A citation does not show that a page influenced an answer, and the same answer can touch more than one row.

The agency would check each page's current contents against primary sources before making any request. Where a page is accurate, the outcome is a no-change decision recorded alongside any justified publisher request.

Step 4. Optimize priority company pages

Questions This Section Answers

  • Which observed US Fertility website pages should receive review briefs?

Company website page

Citation appearances in all captured answers

Benchmark answers citing the page

Recommending answers citing the page

https://usfertility.com/about

10

10

0

https://usfertility.com/

9

9

0

https://usfertility.com/network

9

9

1

https://usfertility.com/locations

5

5

0

http://usfertility.com/

3

0

0

https://usfertility.com/careers

2

1

0

https://usfertility.com/newsroom/us-fertility-and-ovation-come-together-to-form-a-platform-for-growth-and-expansion

2

2

0

https://usfertility.com/newsroom/us-fertility-becomes-the-largest-physician-owned-physician-led-network-of-fertility-practices-in-the-nation

2

2

0

The company's website was cited 50 times across 16 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The company's own pages are cited often, with the about, home and network pages appearing most. Almost none of those citations sit in answers that also recommend the company, so the pages are being read without carrying an endorsement. That is an observation about this sample, not proof that page content caused the gap.

Page briefs would use approved facts and audience questions to sharpen what each priority page says, starting with the pages most often cited. Existing coverage would be checked before any new page is proposed.

Step 5. Publish around buyer questions

Questions This Section Answers

  • Which observed buyer questions support content briefs for US Fertility?

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

best ivf clinics in us

1

1

1

Is US Fertility a legit company?

5

5

0

What does US Fertility do?

5

5

0

Who owns US Fertility?

4

4

0

Is RMA part of MT Sinai?

2

2

0

us fertility

2

2

0

Which fertility clinic has the highest success rate in NYC?

3

1

0

best fertility clinics in the us

1

1

0

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions mix brand checks, ownership questions and clinic-selection queries. Questions about what the company does and who owns it drew mentions without recommendations, which points to content that explains the company plainly and verifiably. Selection questions such as the best clinics drew far fewer appearances.

Buyer-content briefs would address these questions directly, using approved facts and clear language. The agency would first check whether existing pages already answer them well, since these observations are not search volume or proof of missing content.

Our 90-day action plan

Questions This Section Answers

  • How should the agency sequence the proposed US Fertility work and judge completion?

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

The first stage produces a baseline scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner and an evidence requirement. The middle stage turns verified facts into approved page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses recorded separately.

The final stage delivers buyer-content briefs and a fresh scorecard. Completed work would be reported separately from measured answer outcomes, and no gain in visibility would be promised from the work alone.

Methodology

Questions This Section Answers

  • How are US Fertility answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 477 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 665 captured answers and 4163 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Nov 2026

477

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.

Future editions using the same screening scope can be compared against this baseline.

The benchmark covers answers that met its inclusion rules, and the exact collection dates for the original answers have not been verified. A company counts as recommended only when an answer endorses it with positive wording, and placement counts sit inside recommendations rather than adding to them.

Answers can mention several companies, so company counts do not sum to distinct answers. The wider citation analysis covers more answers than the benchmark, and cited pages and disputed claims still need independent verification.

Our first three priorities

The first priority is to verify the ownership and investor claims against primary sources, since they account for the disputed statements and shape how the company is described. Until that check is complete, no correction should be drafted.

The second is to strengthen the most-cited company pages with approved facts and plain answers to the ownership and what-the-company-does questions. The third is to build buyer-question content around clinic selection, where the company currently appears without being recommended. Each piece of work would be tracked separately from any change in measured answers.

This report supports CiteWorks Studio's examination of how AI search is recommending IVF Clinics. For more detail, you can also read IVF Clinics: AI Visibility Discovery Index.

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT